Natural Sciences - Research article Open Access Logo

CHEMICAL CONSTITUENTS FROM LEAVES OF SONNERATIA ALBA J.E. SMITH (SONNERATIACEAE)

Thu Thi Hoai Nguyen 1, *
Khanh Phuc Lam 1
Duy The Nguyen 1
Chanh Thi Kim Huynh 1
Phung Kim Phi Nguyen 1
Poul Erik Hansen 2
  1. University of Science, VNU-HCM
  2. Roskilde University
Correspondence to: Thu Thi Hoai Nguyen, University of Science, VNU-HCM. Email: pvphuc@hcmuns.edu.vn.
Volume & Issue: Vol. 14 No. 4 (2011) | Page No.: 11-17 | DOI: 10.32508/stdj.v14i4.2043
Published: 2011-12-30

Online metrics


Statistics from the website

  • Abstract Views: 1912
  • Galley Views: 851

Statistics from Dimensions

Copyright The Author(s) 2023. This article is published with open access by Vietnam National University, Ho Chi Minh city, Vietnam. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Sonneratia alba J.E. Smith, Sonneratiaceae widely grows in mangrove forests. There were some studies on plants of mangrove forests, and these results showed they contained many interesting bioactive compounds. Nevertheless, Sonneratia alba has not much been studied, especially, has not yet been chemically and biologically studied in Viet Nam. From the petroleum ether extract of the leaves of Sonnertia alba, oleanolic acid (1), betulin (2), betulinic acid (3), alphitolic acid (4), methyl gallate (5) and 5-hydroxymethylfurfural (6) were isolated. Their structures were identified by comparing their NMR data as well as the physical properties with those in literatures. Among them, (1) had high yield (about 0.15% of dried leave) with numerous pharmacological activities including inhibitory activity against HIV-1 protease with IC50 of 6.3 mM, anti-inflammatory, anti-cancer. So, Sonneratia alba should be exploited to afford to a valuable source in food and pharmaceutical products. Further studies on this plant are in progress.

Comments